Table 4.
Maternal/Neonatal Risk Factors Associated With LOS Caused by MDRO
| aOR | 95% CI | P Value | |
|---|---|---|---|
| Maternal chorioamnionitis | 0.76 | [0.07–7.84] | .817 |
| Maternal HIV | 1.02 | [0.56–1.85] | .952 |
| Respiratory distress syndrome | 1.59 | [0.43–5.90] | .491 |
| Mechanical ventilation | 0.89 | [0.50–1.59] | .705 |
| Respiratory support at 36 wk | 1.27 | [0.691–2.35] | .438 |
| Early-onset sepsis | 0.54 | [0.16–1.91] | .343 |
| Fungal sepsis | 0.76 | [0.35–1.66] | .497 |
| Congenital infection | 5.13 | [1.19–22.02] | .028 |
| Necrotizing enterocolitis | 2.17 | [1.05–4.49] | .037 |
| Patent ductus arteriosus | 0.90 | [0.44–1.85] | .782 |
Abbreviations: aOR, adjusted odds ratio (adjusted for birth weight, gestational age, sex, length of hospital stay); LOS, late-onset sepsis; MDRO, multidrug-resistant organism.